On the one hand, Cu can directly bind to PI3K to activate AKT (Ostrakhovitch et al., 2002), and on the other hand, it can activate downstream substrate AKT by binding to 3-phosphoinositide-dependent protein kinase 1 (PDK1), promoting tumor occurrence (Guo et al., 2021). Here, AKT1 is linked to neoplasm.